Definitive Healthcare Corp Stock Performance
| DH Stock | USD 4.25 0.15 3.66% |
The firm shows a Beta (market volatility) of 1.9, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Definitive Healthcare will likely underperform. At this point, Definitive Healthcare has a negative expected return of -0.085%. Please make sure to confirm Definitive Healthcare's maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to decide if Definitive Healthcare performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Definitive Healthcare Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong technical indicators, Definitive Healthcare is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
Actual Historical Performance (%)
One Day Return 4.12 | Five Day Return (1.23) | Year To Date Return (56.40) | Ten Year Return (89.78) | All Time Return (89.78) |
1 | Disposition of 14495 shares by William Moschella of Definitive Healthcare at 3.95 subject to Rule 16b-3 | 09/06/2024 |
2 | Disposition of 1044 shares by Shamsuddin Kate Marie of Definitive Healthcare at 4.44 subject to Rule 16b-3 | 09/13/2024 |
3 | Implied Volatility Surging for Definitive Healthcare Stock Options | 09/17/2024 |
4 | Fred Alger Management LLC Trims Stake in Definitive Healthcare Corp. - MarketBeat | 09/26/2024 |
5 | Acquisition by Shamsuddin Kate Marie of 113379 shares of Definitive Healthcare subject to Rule 16b-3 | 09/27/2024 |
6 | Disposition of 2649 shares by Jason Krantz of Definitive Healthcare at 9.03 subject to Rule 16b-3 | 10/18/2024 |
7 | DH vs. GEHC Which Stock Is the Better Value Option | 10/29/2024 |
8 | Disposition of 7830 shares by Jason Krantz of Definitive Healthcare at 4.18 subject to Rule 16b-3 | 11/01/2024 |
9 | Acquisition by Richard Booth of 92379 shares of Definitive Healthcare subject to Rule 16b-3 | 11/05/2024 |
10 | Earnings To Watch Definitive Healthcare Corp Reports Q3 2024 Result | 11/06/2024 |
11 | Heres Why Baron Discovery Fund Decided to Sell Definitive Healthcare Corp. | 11/07/2024 |
12 | Definitive Healthcare Corp Q3 2024 Earnings Call Highlights Navigating Revenue Challenges ... | 11/08/2024 |
13 | Definitive Healthcare Releases Q4 2024 Earnings Guidance | 11/11/2024 |
14 | DH or PRVA Which Is the Better Value Stock Right Now | 11/18/2024 |
| Begin Period Cash Flow | 146.9 M | |
| Free Cash Flow | 38.2 M |
Definitive |
Definitive Healthcare Relative Risk vs. Return Landscape
If you would invest 458.00 in Definitive Healthcare Corp on August 24, 2024 and sell it today you would lose (33.00) from holding Definitive Healthcare Corp or give up 7.21% of portfolio value over 90 days. Definitive Healthcare Corp is generating negative expected returns and assumes 2.5416% volatility on return distribution over the 90 days horizon. Put differently, 22% of stocks are less risky than Definitive on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Definitive Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Definitive Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Definitive Healthcare Corp, and traders can use it to determine the average amount a Definitive Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0335
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DH |
Estimated Market Risk
| 2.54 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Definitive Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Definitive Healthcare by adding Definitive Healthcare to a well-diversified portfolio.
Definitive Healthcare Fundamentals Growth
Definitive Stock prices reflect investors' perceptions of the future prospects and financial health of Definitive Healthcare, and Definitive Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Definitive Stock performance.
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.0076 | ||||
| Profit Margin | (1.42) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 442.77 M | ||||
| Shares Outstanding | 115.52 M | ||||
| Price To Book | 0.97 X | ||||
| Price To Sales | 1.92 X | ||||
| Revenue | 251.41 M | ||||
| Gross Profit | 196.79 M | ||||
| EBITDA | (241.23 M) | ||||
| Net Income | (202.39 M) | ||||
| Cash And Equivalents | 347.87 M | ||||
| Cash Per Share | 3.46 X | ||||
| Total Debt | 267.93 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 3.32 X | ||||
| Book Value Per Share | 4.39 X | ||||
| Cash Flow From Operations | 41.19 M | ||||
| Earnings Per Share | (3.09) X | ||||
| Market Capitalization | 490.97 M | ||||
| Total Asset | 1.83 B | ||||
| Retained Earnings | (227.45 M) | ||||
| Working Capital | 223.25 M | ||||
About Definitive Healthcare Performance
By evaluating Definitive Healthcare's fundamental ratios, stakeholders can gain valuable insights into Definitive Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Definitive Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Definitive Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 80.05 | 84.05 | |
| Return On Tangible Assets | (0.47) | (0.50) | |
| Return On Capital Employed | (0.20) | (0.19) | |
| Return On Assets | (0.11) | (0.11) | |
| Return On Equity | (0.23) | (0.22) |
Things to note about Definitive Healthcare performance evaluation
Checking the ongoing alerts about Definitive Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Definitive Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Definitive Healthcare generated a negative expected return over the last 90 days | |
| Definitive Healthcare has high likelihood to experience some financial distress in the next 2 years | |
| The company generated the yearly revenue of 251.41 M. Annual Net Loss to common stockholders was (202.39 M) with gross profit of 196.79 M. | |
| Definitive Healthcare has a poor financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from zacks.com: DH or PRVA Which Is the Better Value Stock Right Now |
- Analyzing Definitive Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Definitive Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Definitive Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Definitive Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Definitive Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Definitive Healthcare's stock. These opinions can provide insight into Definitive Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Definitive Stock analysis
When running Definitive Healthcare's price analysis, check to measure Definitive Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definitive Healthcare is operating at the current time. Most of Definitive Healthcare's value examination focuses on studying past and present price action to predict the probability of Definitive Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Definitive Healthcare's price. Additionally, you may evaluate how the addition of Definitive Healthcare to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |